Latest 10-K annual reports

Cenntro Inc.'s 2024 10-K filing reveals a company in transition, focusing on strategic realignment and expansion in the electric vehicle market despite ongoing financial challenges.

J.Jill, Inc. reports a slight increase in net sales for fiscal year 2024 and announces the upcoming retirement of its CEO, Claire Spofford.

Princeton Capital Corporation's latest 10-K filing highlights an ongoing strategic review process amid financial losses and efforts to conserve cash.

Apple iSports Group's 10-K filing reveals significant net losses and a working capital deficit, raising substantial doubt about its ability to continue as a going concern.

Healthy Extracts Inc. files its 10-K report, highlighting a focus on revenue growth, margin maintenance, and positive cash flow in the nutraceuticals market.

Momentus Inc.'s FY2024 results reveal ongoing losses and substantial doubt about its ability to continue as a going concern, despite efforts to secure additional funding and streamline operations.

Chase Packaging Corporation's 10-K filing reveals a reduced net loss for 2024, driven by decreased warrant modification expenses and increased interest income, as the company continues its search for a merger partner or acquisition target.

PVH Corp.'s 10-K filing reveals financial results, strategic initiatives, and risk factors for the fiscal year ended February 2, 2025, highlighting the PVH+ Plan and global brand development.

Nuo Therapeutics reports increased revenues for 2024 and a new distribution agreement with Smith+Nephew for its Aurix product.

Chemed Corporation files an amendment to its 2024 annual report to correct the number of securities available for future issuance under equity compensation plans.

Ultralife Corporation's FY 2024 results show revenue growth driven by the Battery & Energy Products segment, offset by a decline in Communications Systems sales.

SCS LABS Corporation files its annual report on Form 10-K for the Corporate Backed Trust Certificates, Goldman Sachs Capital I Securities-Backed Series 2004-6 Trust, indicating compliance with trust agreements.

I-80 Gold Corp.'s 10-K filing summarizes the company's 2024 financial year, highlighting a new strategic direction focused on underground and open-pit gold projects and a recapitalization plan.

Energy Vault's 10-K filing reveals ongoing losses and a strategic shift towards owning energy storage assets, with revenue generation expected to begin in 2025.

BrooQLy Inc.'s 2024 10-K filing reveals a strategic pivot towards drone technology and autonomous logistics, alongside a change in controlling shareholder and significant financial losses.

Ribbon Acquisition Corporation's 10-K filing details its formation, IPO, business strategy focused on mergers and acquisitions, and financial results for the year ended December 31, 2024, highlighting its search for a suitable target business combination.

Siebert Financial Corp. files an amendment to its 2024 annual report to include the report of its predecessor independent auditor, Baker Tilly US, LLP.

Edible Garden AG Inc. reports its full year 2024 financial results, highlighting revenue of $13.86 million and ongoing efforts to address going concern doubts through strategic shifts and financing activities.

RenovoRx, a life sciences company, announces initial revenue from RenovoCath sales and details its plans for revenue growth and clinical trial progress in 2025.

CareView Communications' 2024 10-K filing reveals a net loss of $4.7 million, a decrease in revenue, and substantial doubt about the company's ability to continue as a going concern.

BluSky AI Inc. reports a net loss for 2024 and details its transition from mining to providing modular data center solutions for the artificial intelligence community.

Safe & Green Holdings Corp.'s 2024 10-K filing reveals a strategic shift with the deconsolidation of SG DevCorp, but also highlights significant liquidity challenges and doubts about the company's ability to continue as a going concern.

Jones Soda Co. saw a revenue increase of 14.9% in 2024, driven by beverage and cannabis sales, but net losses widened due to inventory impairments and increased operating expenses.

Ross Stores finalizes employment agreement with new CEO James G. Conroy, including compensation details and relocation benefits, while also reporting a 3.7% increase in fiscal year 2024 sales.

Data I/O Corporation experienced a decrease in net sales and gross margin in 2024 due to economic and automotive electronics uncertainties, coupled with a key leadership transition.

Reborn Coffee's 2024 annual report reveals recurring losses and a going concern uncertainty, despite a revenue increase driven by new store openings.

Nova LifeStyle reports a net loss for fiscal year 2024, with a focus on strategic shifts and efforts to maintain NASDAQ listing compliance.

Oak Valley Bancorp's net income decreased in 2024 due to rising deposit costs, despite loan growth and a reversal of credit loss provisions.

Allarity Therapeutics streamlines operations to focus on stenoparib, a novel cancer therapeutic, while reporting financial results for the year ended December 31, 2024.

IO Biotech's 10-K filing highlights the company's progress in clinical trials, particularly the Phase 3 trial for Cylembio, and its ongoing development of novel cancer vaccines.